- Home
- ALEC vs ETON Comparison
ALEC vs ETON Comparison
Compare ALEC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- ETON
- Stock Information
- Founded
- ALEC 2013
- ETON 2017
- Country
- ALEC United States
- ETON United States
- Employees
- ALEC N/A
- ETON N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- ALEC Health Care
- ETON Health Care
- Exchange
- ALEC Nasdaq
- ETON Nasdaq
- Market Cap
- ALEC 232.6M
- ETON 199.5M
- IPO Year
- ALEC 2019
- ETON 2018
- Fundamental
- Price
- ALEC $1.86
- ETON $12.58
- Analyst Decision
- ALEC Buy
- ETON Strong Buy
- Analyst Count
- ALEC 6
- ETON 2
- Target Price
- ALEC $11.75
- ETON $15.00
- AVG Volume (30 Days)
- ALEC 2.3M
- ETON 235.4K
- Earning Date
- ALEC 11-06-2024
- ETON 11-12-2024
- Dividend Yield
- ALEC N/A
- ETON N/A
- EPS Growth
- ALEC N/A
- ETON N/A
- EPS
- ALEC N/A
- ETON N/A
- Revenue
- ALEC $61,508,000.00
- ETON $34,677,000.00
- Revenue This Year
- ALEC N/A
- ETON $23.05
- Revenue Next Year
- ALEC $71.71
- ETON $81.27
- P/E Ratio
- ALEC N/A
- ETON N/A
- Revenue Growth
- ALEC N/A
- ETON 5.64
- 52 Week Low
- ALEC $1.73
- ETON $3.03
- 52 Week High
- ALEC $8.90
- ETON $13.98
- Technical
- Relative Strength Index (RSI)
- ALEC 22.54
- ETON 61.05
- Support Level
- ALEC $1.74
- ETON $11.80
- Resistance Level
- ALEC $2.50
- ETON $13.01
- Average True Range (ATR)
- ALEC 0.16
- ETON 0.70
- MACD
- ALEC 0.03
- ETON -0.14
- Stochastic Oscillator
- ALEC 2.37
- ETON 68.46
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.